
Letrust 2.5mg Tablet
Marketer
Synergy Pharma Formulations India Pvt Ltd
Salt Composition
Letrozole (2.5mg)
Overview Letrust 2.5mg Tablet
Postmenopausal women with breast cancer may find relief with Letrust 2.5mg Tablets. This medication can be administered independently or alongside other therapies like surgery or radiotherapy. In advanced breast cancer, it helps curb metastasis. Letrust 2.5mg Tablets may be ingested with or without food, always adhering to your physician's prescribed dosage and duration for optimal results. Dosage frequency varies depending on the treatment goal; your doctor will personalize your regimen for symptom improvement. Continue treatment as directed. Common side effects include vasomotor flushes, weariness, diaphoresis, and elevated cholesterol. Report any concerning or persistent symptoms to your doctor, who can offer management strategies. Prior to commencing treatment, inform your doctor of any pre-existing liver or kidney conditions, osteoporosis, or other medications you're currently using, as interactions may affect Letrust's efficacy. Disclose pregnancy or breastfeeding status to your doctor. Pre- and ongoing treatment blood work, potentially assessing vitamin D levels and bone density, may be recommended.
Primary Ingredients of Letrust 2.5mg Tablet
No text was provided to rewrite.
Uses of Letrust 2.5mg Tablet
Managing breast cancer
Major Benefits of Letrust 2.5mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Letrust 2.5mg Tablets can be consumed with or without food; however, consistent daily timing is recommended.
Common Side effects of Letrust 2.5mg Tablet:
- Dizziness
- Fatigue
- Weakness
- Bone pain
- Back pain
- Night sweats
- Joint pain
- Nausea
- Osteoporosis
- Joint inflammation
- Weight gain
- Hot flushes
- Edema (swelling)
- Flushing (sense of warmth in the face, ears, neck and trunk)
- Diaphoresis
- Bone fracture
- Hypercholesterolemia (high cholesterol)
- Cough
- Shortness of breath
How to use Letrust 2.5mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Letrust 2.5mg Tablets can be consumed with or without food, though consistent timing is recommended.
How Letrust 2.5mg Tablet works:
Estrogen production is reduced by Letrust 2.5mg Tablets, an aromatase inhibitor. This lowered estrogen level inhibits the growth of certain estrogen-dependent breast cancers.
SAFETY ADVICE
AlcoholSAFE
Letrust 2.5mg Tablet may be taken with alcohol without adverse reactions.
PregnancyUNSAFE
Using Letrust 2.5mg tablets during pregnancy poses a serious risk. Pregnant women should consult their physician immediately, as research in animals and pregnant humans has revealed substantial adverse effects on fetal development.
Breast feedingUNSAFE
Administering Letrust 2.5mg tablets while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Taking a 2.5mg Letrust tablet might reduce attentiveness, impair vision, and cause drowsiness or dizziness. Refrain from driving if you experience these effects.
KidneySAFE IF PRESCRIBED
For individuals with kidney disease, Letrust 2.5mg Tablet is considered safe, and no dosage alteration is typically necessary. Limited data exists regarding its use in those with end-stage renal disease; therefore, physician consultation is advised.
LiverCAUTION
Patients with liver impairment should exercise caution when using Letrust 2.5mg tablets; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Letrust 2.5mg Tablet :
Should you forget a Letrust 2.5mg Tablet dose, take it immediately. If your next dose is imminent, however, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Letrust 2.5mg Tablet
| Label | Value |
|---|---|
| Chemical Classification | Diphenylmethane derivative |
| Developing Good Habits | No. |
| Treatment Category | Cancer Therapeutics |
